Skip to content

Clinical study of inhaling Bronchodilator with heliox driven for acute exacerbation of chronic obstructive pulmonary disease (COPD)

Clinical study of inhaling Bronchodilator with heliox driven for acute exacerbation of chronic obstructive pulmonary disease (COPD)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-08000273
Enrollment
Unknown
Registered
2008-05-05
Start date
2008-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease (COPD)

Interventions

Group A:Routine drug inhalation atomized by mixture of air and oxygen
Group B:Drug inhalation atomized by variant partial ratio of heliox, and the samples come from group A

Sponsors

PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients in ordinary endemic area of respiratory disease; 2. fit the definition of COPD set by GOLD 2006, and accord with the definition based on medical record, physical examination, and sternite; 3. Mind distinctness, to be able to match; 4. Vital sign steady; 5. No other organ apparent functional insufficiency (such as heart, liver and kidney, ect.)

Exclusion criteria

Exclusion criteria: 1. Refuse the use of heliox for treating; 2. pH <7.30; 3. Mind abstacle, Glasgow score<8; 4. Other organ functional insufficiency(such as heart, liver and kidney, ect) 5. Septic shock; 6. Apnoea; 7. Unable to match or unsuitable for veil.

Design outcomes

Primary

MeasureTime frame
SpO2 (%), pH, PaO2 (mmHg), PaCO2 (mmHg), HCO3- (mmol/L), FVC(ml), FEV1(ml), FEV1%, PEF(ml), FRC(ml);

Secondary

MeasureTime frame
Respiratory rate, cardioverter, dyspnea score, assistant respiratory acting score;

Countries

China

Contacts

Public ContactXie Lixin
xielx@301hospital.com.cn+86 0 13911252807

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026